Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.02 - $10.99 $68,086 - $124,296
11,310 New
11,310 $69,000
Q1 2021

May 03, 2021

SELL
$6.21 - $8.68 $103,489 - $144,652
-16,665 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$5.99 - $8.55 $12,770 - $18,228
2,132 Added 14.67%
16,665 $151,000
Q2 2020

Aug 10, 2020

BUY
$5.43 - $9.39 $78,914 - $136,464
14,533 New
14,533 $119,000

Others Institutions Holding FENC

About FENNEC PHARMACEUTICALS INC.


  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $156M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.